Gilead Sciences Inc (GILD) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Gilead Sciences Inc   (NASDAQ: GILD)
 

Gilead Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Gilead Sciences Inc 's inventory turnover ratio sequentially decreased to 3.35 in the second quarter 2026, otherwise the ratio remained above the average, as GILD's markets remain strong.Average processing period, for Gilead Sciences Inc 's inventories remained unchanged at 109 days, in the Jun 30 2026 quarter.

Within Healthcare sector 114 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1145, from total ranking in the first quarter 2026 at 1248.

GILD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gilead Sciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GILD Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 7.01 % 8.81 % 3.74 % -4.49 % -9.92 %
Y / Y Cost of Sales Growth 5.2 % -6.17 % 2.72 % -0.32 % -2.78 %
Inventory Turnover Ratio (TTM) 3.35 3.36 3.49 3.5 3.46
GILD's Total Ranking # 1145 # 1248 # 1148 # 1149 # 1167
Average inventory processing period 109 108 105 104 105
Seq. Inventory Growth 2.04 % 7.89 % -0.62 % -2.19 % 3.75 %
Seq. Cost of Sales Growth 9.27 % -11.02 % 3.51 % 4.53 % -2.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 12
Healthcare Sector # 115
Overall Market # 1145

Inventory Turnover Ratio Statistics
High Average Low
5.75 2.69 1.16
(Dec 31 2018)   (March 31, 2007)



GILD Company Profile >> Back to GILD Efficiency Comparisons >> Compare GILD Inventory Turnover Ratio to its Competitors

Financial Statements
Gilead Sciences Inc 's Inventories $ 1,953 Millions Visit GILD's Balance sheet
Gilead Sciences Inc 's Cost of Revenues TTM $ 6,217 Millions Visit GILD's Income Statement
What are GILD's Sales? Visit GILD's Sales by Segment

Other Inventory Turnover Ratios
Gilead Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GILD's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GILD's Competitors
Inventory Turnover Ratio for GILD's Suppliers
Inventory Turnover Ratio for GILD's Customers

You may also want to know
GILD's Sales Growth Rates GILD's Pe Price to earnings ratio GILD's Receivables Turnover Ratio GILD's Stock Quote
GILD's Net Income Growth Rates GILD's Ps Price to Sales ratio GILD's Sales per Employee GILD's Asset Turnover Ratio
GILD's Net Margin GILD's Pb Price to Book ratio GILD's Financial Strength Ratios GILD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions

Date modified: 2026-09-08T15:11:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.